Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Anavex Life Sciences Corp. (12X1.F)

Compare
7.91
+0.21
+(2.70%)
At close: April 15 at 9:00:34 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Operating Expense
55,004
52,802
55,731
50,986
41,948
Operating Income
-55,004
-52,802
-55,731
-50,986
-41,948
Net Non Operating Interest Income Expense
6,706
7,320
5,555
947
26
Other Income Expense
1,807
2,480
2,678
2,419
4,281
Pretax Income
-46,491
-43,002
-47,498
-47,620
-37,641
Tax Provision
--
--
7
358
268
Net Income Common Stockholders
-46,491
-43,002
-47,505
-47,978
-37,909
Diluted NI Available to Com Stockholders
-46,491
-43,002
-47,505
-47,978
-37,909
Basic EPS
-0.55
-0.52
-0.60
-0.62
-0.54
Diluted EPS
-0.55
-0.52
-0.60
-0.62
-0.54
Basic Average Shares
84,150.09
83,468.05
79,787.60
76,909.99
69,802.96
Diluted Average Shares
84,150.09
83,468.05
79,787.60
76,909.99
69,802.96
Total Operating Income as Reported
-55,091
-52,877
-55,756
-50,986
-42,002
Total Expenses
55,004
52,802
55,731
50,986
41,948
Net Income from Continuing & Discontinued Operation
-46,491
-43,002
-47,505
-47,978
-37,909
Normalized Income
-46,187
-43,191
-47,473.40
-47,263.84
-37,714.82
Interest Income
6,706
7,320
6,519
947
26
Interest Expense
--
--
964
--
--
Net Interest Income
6,706
7,320
5,555
947
26
EBIT
-45,204
-43,002
-46,534
-47,620
-37,641
EBITDA
-45,204
-43,002
-46,534
-47,620
-37,641
Net Income from Continuing Operation Net Minority Interest
-46,491
-43,002
-47,505
-47,978
-37,909
Total Unusual Items Excluding Goodwill
-304
189
-40
-904
-266
Total Unusual Items
-304
189
-40
-904
-266
Normalized EBITDA
-44,900
-43,191
-46,494
-46,716
-37,375
Tax Rate for Calcs
--
--
0
0
0
Tax Effect of Unusual Items
--
--
-8.40
-189.84
-71.82
9/30/2021 - 4/28/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RXK3.MU SELLAS Life Sciences Group Inc
1.0470
+5.49%
 
SAVA.MX Cassava Sciences, Inc.
57.20
+0.12%
 
I9SA.HA Verona Pharma PLC
51.80
+0.78%
 
IPSC Century Therapeutics, Inc.
0.5010
+0.36%
 
KYTX Kyverna Therapeutics, Inc.
1.9850
-10.99%
 
ANVS Annovis Bio, Inc.
1.2200
-1.61%
 
CRDF Cardiff Oncology, Inc.
2.9400
+5.38%
 
CYTK Cytokinetics, Incorporated
38.56
-3.14%
 
SANA Sana Biotechnology, Inc.
1.7000
-6.08%
 
GPCR Structure Therapeutics Inc.
18.90
-0.26%